<unk>  is indicated for the treatment of people with relapsed or refractory peripheral T-cell lymphoma (PTCL).
Pralatrexate
Trimetrexate
Abemaciclib
Afamelanotide
Cemiplimab
Mannomustine
Trifluridine
Lenalidomide